Results 21 to 30 of about 787 (101)

Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy: insights from a clinical case series [PDF]

Arquivos de Neuro-Psiquiatria
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by the deposition of amyloid-beta in small cerebral vessels, which can lead to intracerebral hemorrhages and cognitive impairment.
Ana Silvia Sobreira Lima Verde, Alessandra Braga Cruz Guedes de Morais, Amanda Vale Catunda, João Igor Dantas Landim, Ian Silva Ribeiro, Bruno Diógenes Iepsen, Norberto Anízio Ferreira Frota   +6 more
doaj   +2 more sources

Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting

Swiss Medical Weekly, 2016
QUESTIONS UNDER STUDY: Alzheimer-type amyloid-β (Aβ) pathology was reported in brains of individuals developing iatrogenic Creutzfeldt-Jakob disease (iCJD) after treatment with human cadaveric growth hormone, and interpreted as evidence of human ...
Karl Frontzek, Mirjam I. Lutz, Adriano Aguzzi, Gabor G. Kovacs, Herbert Budka   +4 more
doaj   +4 more sources

Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series. [PDF]

Neurol Neuroimmunol Neuroinflamm
Variants of cerebral amyloid angiopathy (CAA) have been increasingly reported. Iatrogenic CAA (iCAA) is a subtype arising in patients with a history of neurosurgery. Current etiopathogenetic hypotheses focus on previous exposure to contaminated materials, such as cadaveric dura, followed by a prion-like mechanism.
Storti B, Negro G, Orsani G, Damavandi PT, Donelli M, Cavarsaschi E, Conti E, Sala G, Zoia CP, Ferrarese C, Stanziano M, Canavero I, Bersano A, DiFrancesco JC.   +13 more
europepmc   +4 more sources

Medicolegal aspects of iatrogenic cerebral amyloid angiopathy. [PDF]

Surg Neurol Int
Jensen-Kondering U.
europepmc   +2 more sources

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy. [PDF]

Alzheimers Dement
Abstract INTRODUCTION Iatrogenic transmission of amyloid beta can cause cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD), but the relationship between these phenotypes is unclear.
Panteleienko L, Banerjee G, Mallon D, Chan E, Fandler-Höfler S, Oliver R, Harvey V, Jaunmuktane Z, Collinge J, Werring DJ.   +9 more
europepmc   +2 more sources

Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon

Journal of Neurology, Neurosurgery & Psychiatry, 2022
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ) transmission in humans (in 2015) and subsequent experimental confirmation (in 2018), clinical cases of iatrogenic cerebral amyloid angiopathy (CAA)—attributed to the transmission of Aβ seeds—have been increasingly recognised and reported.
Gargi Banerjee, Kiran Samra, Matthew E Adams, Zane Jaunmuktane, Adrian Robert Parry-Jones, Joan Grieve, Ahmed K Toma, Simon F Farmer, Richard Sylvester, Henry Houlden, Peter Rudge, Simon Mead, Sebastian Brandner, Jonathan M Schott, John Collinge, David J Werring   +15 more
openaire   +3 more sources

Iatrogenic Cerebral Amyloid Angiopathy after Cadaveric Dura Mater Transplantation to an Intact Brain Surface: A Case Report [PDF]

NMC Case Report Journal
Tsuyoshi Hamaguchi
exaly   +2 more sources

Spontaneous intracerebral haemorrhage associated with early-onset cerebral amyloid angiopathy and Alzheimer’s disease neuropathological changes five decades after cadaveric dura mater graft

Acta Neuropathologica Communications, 2023
Cerebral amyloid angiopathy (CAA) is a small vessel disease, causing spontaneous intracerebral hemorrhage (ICH) in the elderly. It is strongly associated with Alzheimer disease (AD), as most CAA patients show deposition of Aβ—i.e.
Riccardo Milani, Lucio Aniello Mazzeo, Daniela Vismara, Ilaria Salemi, Emanuele Dainese, Emanuela Maderna, Elisa Pellencin, Marcella Catania, Nicole Campanella, Giuseppe Di Fede, Giorgio Giaccone, Andrea Salmaggi   +11 more
doaj   +1 more source

CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy. [PDF]

Neurology
Recently, a subset of patients affected by cerebral amyloid angiopathy (CAA) distinguished by atypical juvenile onset and a hypothesized iatrogenic origin (iatrogenic CAA, iCAA) has emerged. β-Amyloid (Aβ) accumulation evidenced by amyloid PET positivity or CSF Aβ decrease was included in the iCAA diagnostic criteria.
Pollaci G, Potenza A, Gorla G, Carrozzini T, Marinoni G, De Toma C, Canavero I, Rifino N, Boncoraglio GB, Difrancesco JC, Damavandi PT, Stanziano M, Erbetta A, Caroppo P, Di Fede G, Catania M, Zulueta A, Parati EA, Bersano A, Gatti L, Storti B.   +20 more
europepmc   +5 more sources

Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA

Frontiers in Neuroscience, 2023
Thanks to a more widespread knowledge of the disease, and improved diagnostic techniques, the clinical spectrum of cerebral amyloid angiopathy (CAA) is now broad.
Benedetta Storti, Maria Magdalena Gabriel, Maria Magdalena Gabriel, Stefan Sennfält, Isabella Canavero, Nicola Rifino, Laura Gatti, Anna Bersano   +7 more
doaj   +1 more source